These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1608498)

  • 1. [Rifampicin protocol--protamine administered by central venous catheters in hemodialysis].
    Montagnac R; Schillinger F
    Nephrologie; 1992; 13(2):101-2. PubMed ID: 1608498
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apropos of rifampicin-protamine protocol used in the prevention of infections from central venous catheters in hemodialysis].
    Montagnac R; Schillinger F
    Nephrologie; 1994; 15(5):361. PubMed ID: 7816167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of bacteremia from central venous catheters in hemodialysis: value of application of a mixture of rifampicin and protamine at the insertion site].
    Montagnac R; Schillinger F; Eloy C
    Nephrologie; 2003; 24(4):159-65. PubMed ID: 12891830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifampicin-protamine protocol applied to central venous catheters during hemodialysis. L'Equipe Infirmière].
    Montagnac R; Schillinger F
    Nephrologie; 1994; 15(2):163-4. PubMed ID: 8047205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin-protamine protocol applied for prevention of central catheter sepsis in haemodialysis.
    Montagnac R; Schillinger F
    Nephrol Dial Transplant; 1993; 8(3):289-90. PubMed ID: 8385301
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
    Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rifampicin-protamine sulfate solution in dialysis patients].
    Lecame M; Legras S; Ficheux M; Henri P; Ryckelynck JP; Lobbedez T
    Nephrol Ther; 2008 Oct; 4(5):330-4. PubMed ID: 18455487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recirculation of urea and dialysis efficiency using dual-lumen dialysis catheters in various locations: may the venous lumen of the catheter be used as the arterial lumen and vice versa?].
    Sefer S; Kes P; Degoricija V; Heinrich B; Vrsalović M
    Lijec Vjesn; 2003; 125(1-2):1-5. PubMed ID: 12812016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sampling for international normalized ratios in patients on hemodialysis with central venous catheters.
    Boyd A; Dunne A; Townsend K; Pai AB
    Nephrol Nurs J; 2006; 33(4):408-11. PubMed ID: 17001998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood recirculation in temporary central catheters for acute hemodialysis.
    Leblanc M; Fedak S; Mokris G; Paganini EP
    Clin Nephrol; 1996 May; 45(5):315-9. PubMed ID: 8738663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters.
    Peynircioglu B; Ozkan F; Canyigit M; Cil BE; Balkanci F
    Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare complication of hemodialysis catheters: superior vena cava syndrome.
    Akoglu H; Yilmaz R; Peynircioglu B; Arici M; Kirkpantur A; Cil B; Altun B; Turgan C
    Hemodial Int; 2007 Oct; 11(4):385-91. PubMed ID: 17922732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis central venous catheter dysfunction.
    Chan MR
    Semin Dial; 2008; 21(6):516-21. PubMed ID: 19000124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia.
    Dittmer ID; Sharp D; McNulty CA; Williams AJ; Banks RA
    Clin Nephrol; 1999 Jan; 51(1):34-9. PubMed ID: 9988144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance of permanent central venous access for hemodialysis].
    Bosc JY; Martin K; Leray-Moragues H; Canaud B
    Nephrologie; 2001; 22(8):413-5. PubMed ID: 11810999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary results of a prospective study on predictive factors for infection linked to central venous catheters of hemodialysis].
    Lavigne T; De Almeida N; Meunier O; Petitjean P; Hannedouche T
    Nephrologie; 2001; 22(8):407-8. PubMed ID: 11810997
    [No Abstract]   [Full Text] [Related]  

  • 20. Venous access for chronic hemodialysis: "undesirable yet unavoidable".
    Desmeules S; Canaud B
    Artif Organs; 2004 Jul; 28(7):611-6. PubMed ID: 15209852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.